TOPEKA, Kan. (WIBW) - The impact of the University of Kansas Cancer Center in Kansas City being designated as a National Cancer Institute is being felt at facilities around the region, including the Stormont-Vail Cancer Center in Topeka.
KU's Cancer Center is linked to more than a dozen other medical facilities in Kansas and Missouri through the Midwest Cancer Alliance. Topeka's Stormont-Vail is part of its Partners Advisory Board.
Oncologist David Einspahr with the Stormont-Vail Cancer Center says the KU Cancer Center's NCI designation makes it an exciting time for doctors around the state. Through creation of the Midwest Cancer Alliance, the new opportunities available at KU's Cancer Center will trickle down to Topeka.
Dr. Einspahr says the access to the latest trials and medications mean Topeka facilities will be able to participate on a whole other level of study they had not previously been able to. Dr. Einspahr says new study drugs and treatments and trials for which KU is now eligible will be open to patients in Topeka.
In addition, the application process saw KU expanding its staff of oncologists, many of whom bring their expertise right to the patients at the Alliance facilities. Dr. Einspahr says that is a big relief for patients who want to seek out second opinions or additional consultations without having to go through the hardship of traveling to another city while they are sick.
Dr. Eiinspahr says the designation not only puts Midwest Cancer Alliance facilities on the front lines of finding new breakthroughs, it also offers something immeasurable to patients - hope. He says being able to offer additional options can be the difference between giving up and continuing the fight.
St. Francis Health Center, Kansas State University and the Kansas Bioscience Authority also are members of the Alliance.